Literature DB >> 6665525

Amino acid sequences in amyloid proteins of kappa III immunoglobulin light-chain origin.

K Sletten, P Westermark, P Pitkänen, N Thyresson, O K Olstad.   

Abstract

The main amyloid fibril (AL) proteins extracted from the spleen of Patient So 124 with systemic amyloidosis and from a skin nodule of Patient KSA with localized amyloidosis were studied by partial amino acid sequence analysis and proved to be of kappa III immunoglobulin light-chain origin. The sequences were similar to that of Bence Jones protein V and, which has been reported to have a unique kappa III subset sequence. Thus, except for position 9 in protein AL(KSA), the amino acid sequences were identical to position 25 in AL(So 124) and in AL(KSA). The question is being raised whether this kappa III subset might contain amyloidogenic sequences.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6665525     DOI: 10.1111/j.1365-3083.1983.tb00891.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III.

Authors:  E Holm; K Sletten; G Husby
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

2.  Two different pathogenetic pathways in lichen amyloidosus and macular amyloidosis.

Authors:  P Westermark; P Norén
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein.

Authors:  T Tveteraas; K Sletten; P Westermark
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

Review 4.  Localized AL amyloidosis: a suicidal neoplasm?

Authors:  Per Westermark
Journal:  Ups J Med Sci       Date:  2012-02-15       Impact factor: 2.384

5.  A murine hybridoma with large cytoplasmic inclusions of kappa light chains.

Authors:  D C Reason
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.